抄録
The viral enzyme integrase is essential for the replication of human immunodeficiency virus type 1 (HIV-1) and represents a remaining target for antiretroviral drugs. Here, we describe the modification of a quinolone antibiotic to produce the novel integrase inhibitor JTK-303 (GS 9137) that blocks strand transfer by the viral enzyme. It shares the core structure of quinolone antibiotics, exhibits an IC50 of 7.2 nM in the strand transfer assay, and shows an EC50 of 0.9 nM in an acute HIV-1 infection assay.
本文言語 | English |
---|---|
ページ(範囲) | 1506-1508 |
ページ数 | 3 |
ジャーナル | Journal of Medicinal Chemistry |
巻 | 49 |
号 | 5 |
DOI | |
出版ステータス | Published - 2006 3月 5 |
外部発表 | はい |
ASJC Scopus subject areas
- 分子医療
- 創薬